PML野生型和基因敲除细胞对抗癌药物LDM的反应提示正常细胞和癌细胞对抗肿瘤药物反应过程中PML蛋白不是唯一的途径。
The reaction of anticancer drug LDM with PML-wild-type and-knockout cells may elucidate that its not the unique pathway in the mechanism of LDM's action on normal and cancer cells.
结论32p标记供体白细胞预处理受体免疫学指标未见显著改变，提示该方法是安全可靠的，为抗角膜移植免疫排斥反应提供了新的手段。
Conclusion The immunological indexes were not significantly changed after pretreatment of receptor by 32p labeled white blood cell, suggesting that such treatment is safe for cornea transplantation.
应用推荐